X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (127) 127
oncology (119) 119
index medicus (111) 111
male (104) 104
middle aged (85) 85
aged (80) 80
female (69) 69
treatment outcome (56) 56
cancer (55) 55
adult (53) 53
article (46) 46
kidney neoplasms - drug therapy (45) 45
urology & nephrology (45) 45
carcinoma, renal cell - drug therapy (41) 41
chemotherapy (41) 41
metastasis (40) 40
survival (39) 39
aged, 80 and over (37) 37
antineoplastic combined chemotherapy protocols - therapeutic use (35) 35
neoplasm metastasis (35) 35
antineoplastic agents - therapeutic use (33) 33
care and treatment (33) 33
urology (32) 32
kidney neoplasms - pathology (31) 31
prostate cancer (31) 31
disease-free survival (29) 29
survival analysis (28) 28
clinical trials (27) 27
carcinoma (26) 26
prognosis (26) 26
retrospective studies (26) 26
carcinoma, renal cell (24) 24
research (24) 24
kidney neoplasms - mortality (22) 22
therapy (22) 22
carcinoma, renal cell - mortality (21) 21
sunitinib (21) 21
tumors (21) 21
hematology, oncology and palliative medicine (20) 20
antineoplastic combined chemotherapy protocols - adverse effects (19) 19
docetaxel (19) 19
immunotherapy (19) 19
kaplan-meier estimate (19) 19
kidney cancer (19) 19
cisplatin (18) 18
drug therapy (18) 18
interferon-alpha (18) 18
medicine & public health (18) 18
patient outcomes (18) 18
carcinoma, renal cell - pathology (17) 17
combination (17) 17
everolimus (17) 17
abridged index medicus (16) 16
deoxycytidine - analogs & derivatives (16) 16
proportional hazards models (16) 16
sorafenib (16) 16
trial (16) 16
disease progression (15) 15
prostatic neoplasms - drug therapy (15) 15
renal cell carcinoma (15) 15
drug administration schedule (14) 14
prostatic neoplasms - pathology (14) 14
survival rate (14) 14
targeted therapy (14) 14
vascular endothelial growth factor (14) 14
antineoplastic agents - administration & dosage (13) 13
antineoplastic agents - adverse effects (13) 13
carcinoma, renal cell - secondary (13) 13
neoplasm staging (13) 13
open-label (13) 13
prostate-specific antigen - blood (13) 13
antimitotic agents (12) 12
antineoplastic agents (12) 12
antineoplastic combined chemotherapy protocols - administration & dosage (12) 12
carcinoma, transitional cell - drug therapy (12) 12
doxorubicin (12) 12
efficacy (12) 12
expression (12) 12
gemcitabine (12) 12
molecular targeted therapy (12) 12
multicenter (12) 12
pharmacology & pharmacy (12) 12
urothelial carcinoma (12) 12
bladder cancer (11) 11
deoxycytidine - administration & dosage (11) 11
double-blind (11) 11
follow-up studies (11) 11
protein kinase inhibitors - therapeutic use (11) 11
urinary bladder neoplasms - drug therapy (11) 11
analysis (10) 10
angiogenesis (10) 10
bevacizumab (10) 10
clinical trials as topic (10) 10
combined modality therapy (10) 10
health aspects (10) 10
metastases (10) 10
mitoxantrone (10) 10
patients (10) 10
pharmacology/toxicology (10) 10
prednisone (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 10/2018, Volume 24, Issue 20, pp. 4918 - 4920
It is imperative to develop a comprehensive toxicity score that will capture, convey, and compare adverse events of agents that are therapeutic options for the... 
ONCOLOGY
Journal Article
JOURNAL OF ONCOLOGY PRACTICE, ISSN 1554-7477, 08/2019, Volume 15, Issue 8, pp. 431 - 431
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10064, pp. 67 - 76
Journal Article
Current Treatment Options in Oncology, ISSN 1527-2729, 1/2018, Volume 19, Issue 1, pp. 1 - 9
With no therapy specifically approved for non-clear cell cancers of the kidney, this disease remains an orphan site. Clear cell renal cancers (ccRCC) have seen... 
Papillary | Sarcomatoid | Medicine & Public Health | Renal cancer | Unclassified | Oncology | Medullary | Non-clear cell | Chromophobe | MULTICENTER | CYTOREDUCTIVE NEPHRECTOMY | TUMORS | ONCOLOGY | SUNITINIB | MUTATIONS | CARCINOMA | Care and treatment | Diagnosis | Research | Kidney cancer | Cancer cells
Journal Article
Translational Cancer Research, ISSN 2218-676X, 02/2019, Volume 8, Issue 1, pp. 7 - 10
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 378 - 388
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 3, pp. 293 - 300
Journal Article
Current Opinion in Oncology, ISSN 1040-8746, 03/2017, Volume 29, Issue 3, pp. 196 - 200
PURPOSE OF REVIEWProstate cancer presents with a multitude of faces. It ranges from localized cancers staying quiescent for many years during active... 
targeted therapy | prostate cancer | CARBOPLATIN | GENOMICS | THERAPY | ONCOLOGY | RANDOMIZED PHASE-II | immunotherapy | castration resistance | treatment optimization
Journal Article
The Lancet Oncology, ISSN 1470-2045, 03/2018, Volume 19, Issue 3, pp. 405 - 415
Journal Article
Nature Reviews Urology, ISSN 1759-4812, 01/2015, Volume 12, Issue 1, pp. 13 - 14
In the field of advanced prostate cancer, a number of therapeutic agents are now available. The sequence of administration of medications with distinct... 
Care and treatment | Chemotherapy | Diagnosis | Research | Prostate cancer | Health aspects | Cancer
Journal Article
European Oncology and Haematology, ISSN 2045-5275, 2018, Volume 14, Issue 2, pp. 74 - 75
Journal Article
Current treatment options in oncology, 01/2018, Volume 19, Issue 1, p. 5
With no therapy specifically approved for non-clear cell cancers of the kidney, this disease remains an orphan site. Clear cell renal cancers (ccRCC) have seen... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 4, pp. 412 - 419
Journal Article